Supernus Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Raised Its FY24 Revenue Guidance.
Supernus Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Raised Its FY24 Revenue Guidance.
supernus pharmaceuticals公佈了Q2財務業績超過預期並提高FY24營業收入預期後，其股票交易價格上漲。
Supernus Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Raised Its FY24 Revenue Guidance.
supernus pharmaceuticals公佈了Q2財務業績超過預期並提高FY24營業收入預期後，其股票交易價格上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。